366 related articles for article (PubMed ID: 12210031)
21. Multi-visceral resection for locally advanced gastric cancer.
Bloechle C; Izbicki JR; Limmer J; Kühn R; Hosch SB; Busch C; Rogiers X; Broelsch CE
Acta Chir Belg; 1995; 95(2):72-5. PubMed ID: 7754735
[TBL] [Abstract][Full Text] [Related]
22. The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Kim S
Am J Surg; 2007 Aug; 194(2):143-7. PubMed ID: 17618792
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopically-assisted palliative total gastrectomy in patients with stage IV or metastatic gastric cancer: is it worthwhile?
Du J; Li J; Li Y; Ji G; Yang Z; Gao Z; Zheng J
Hepatogastroenterology; 2008; 55(86-87):1908-12. PubMed ID: 19102420
[TBL] [Abstract][Full Text] [Related]
24. [Risk factors for oncologic outcome after surgical treatment in patients with gastric cancer: a multivariable analysis of 1031 patients].
Li XB; Zhang HW; Zhao QC; Dong GL; Wang WZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):115-8. PubMed ID: 20186621
[TBL] [Abstract][Full Text] [Related]
25. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer.
Cheong JH; Shen JY; Song CS; Hyung WJ; Shen JG; Choi SH; Noh SH
Ann Surg Oncol; 2007 Jan; 14(1):61-8. PubMed ID: 17058123
[TBL] [Abstract][Full Text] [Related]
26. Bleeding, obstruction, and perforation in a series of patients with aggressive gastric lymphoma treated with primary chemotherapy.
Spectre G; Libster D; Grisariu S; Da'as N; Yehuda DB; Gimmon Z; Paltiel O
Ann Surg Oncol; 2006 Nov; 13(11):1372-8. PubMed ID: 17009162
[TBL] [Abstract][Full Text] [Related]
27. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].
Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796
[TBL] [Abstract][Full Text] [Related]
28. Prognosis of patients with resection of stage IV gastric cancer.
Murata S; Terata N; Eguchi Y; Tani T; Shibata J; Kodama M
Int Surg; 1998; 83(4):283-6. PubMed ID: 10096742
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological characteristics and prognosis of remnant stomach cancer--report of 45 cases].
Xu DK; Zhao P; Wang CF; Shao YF; Lin HW; Tian YT
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):852-4. PubMed ID: 17416009
[TBL] [Abstract][Full Text] [Related]
30. Predictors of long-term survival in pN3 gastric cancer patients.
Kim J; Cheong JH; Hyung WJ; Shen J; Choi SH; Noh SH
J Surg Oncol; 2004 Oct; 88(1):9-13. PubMed ID: 15384089
[TBL] [Abstract][Full Text] [Related]
31. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
[TBL] [Abstract][Full Text] [Related]
32. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma].
Zhan WH; Han FH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):17-22. PubMed ID: 16437364
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
34. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
Cheong O; Kim BS; Yook JH; Oh ST; Park YK; Ryu SY
J Surg Oncol; 2008 Dec; 98(7):500-4. PubMed ID: 18770520
[TBL] [Abstract][Full Text] [Related]
35. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
36. Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer.
Cheong JH; Hyung WJ; Chen J; Kim J; Choi SH; Noh SH
J Surg Oncol; 2004 Jul; 87(1):39-45. PubMed ID: 15221918
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H
Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548
[TBL] [Abstract][Full Text] [Related]
38. Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells.
Wu CC; Chen JT; Chang MC; Ho WL; Chen CY; Yeh DC; Liu TJ; P'eng FK
J Am Coll Surg; 1997 Jun; 184(6):611-7. PubMed ID: 9179118
[TBL] [Abstract][Full Text] [Related]
39. The radical treatment of gastric carcinoma.
Ranzato R; Fiamingo P; Veroux M; D'Amico DF
Minerva Chir; 2004 Oct; 59(5):471-7. PubMed ID: 15494674
[TBL] [Abstract][Full Text] [Related]
40. Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer?
Bennett JJ; Gonen M; D'Angelica M; Jaques DP; Brennan MF; Coit DG
J Am Coll Surg; 2005 Oct; 201(4):503-10. PubMed ID: 16183487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
